[1] |
TAI Jun, YU Miao, ZHANG Lin, LEI Yi, LIU Junting, LI Tao, HUANG Guimin, CHENG Yijing, NIE Xiaolu, WANG Qing.
Active monitoring of adverse reactions related to haemocoagulase agkistrodon for injection in children
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1011-1016.
|
[2] |
ZHENG Yujing, ZHAO Zinan, JIN Pengfei, ZHAO Fei, HU Xin, ZHANG Yatong.
Active monitoring of adverse reactions of capecitabine-induced hand-foot syndrome based on the hospital information system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 441-443.
|
[3] |
ZHAO Yan, LIU Wenbo, ZHAO Yifei, LI Dong, ZHENG Lijia, SONG Yana, ZHAO Yujuan, DONG Fang.
Applicability of patient registry research to regulation of medical devices
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 423-427.
|
[4] |
ZHAO Yan, LI Yao, SONG Ya’na, ZHENG Lijia, LI Dong, ZHAO Yifei, BIAN Rongrong, DONG Fang.
Post-marketing active monitoring of medical devices under vigilance
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1385-1390.
|
[5] |
ZHENG Yi, ZHAI Yinghong, GUO Xiaojing, XU Jinfang, CHI Lijie, GUO Zhijian, CHEN Chenxin, LIANG Jizhou, WEI Lianhui, CHEN Xiao, YE Xiaofei, HE Jia.
Thyroid immune-related adverse reactions of immune checkpoint inhibitors
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 92-95.
|
[6] |
XIONG Daiqin, MA Xueying, TENG Liang, WANG Jie.
An Active Model for Monitoring and Early Warning of Cephalosporin Adverse Drug Reactions in Pediatrics Using Global Trigger Tools
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 663-668.
|
[7] |
CAI Meng, LI Min, SHEN Aizong.
Active Monitoring of Adverse Drug Reactions Caused by Anti-tumor Targeted Drugs
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(4): 368-372.
|
[8] |
WU Fei, LI Min, FANG Yuting, CHEN Yongwu, SHEN Aizong.
Active Monitoring of Adverse Drug Reactions Caused by Lopinavir/ritonavir in Treating Coronavirus Disease 2019
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 105-109.
|
[9] |
ZHOU Hong, XU Ning, ZHANG Xiao, CHEN Gang, LIU Yanjie, YU Xiaojia, GONG Lili, LIU Lihong.
Data Analysis of Oseltamivir Adverse Reactions in 55 Cases
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(7): 420-424.
|
[10] |
WANG Dan, DONG Duo.
Discussion on the Key Drug Monitoring in China
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(9): 534-537.
|
[11] |
WANG Hong, YANG Li-jun, DENG Jian-xiong, XING Xin, LIN Guo-liang, LU Shu-tang.
Investigating and Analyzing the Orthopedic Implants Administration Events in Guangdong Province
[J]. Chinese Journal of Pharmacovigilance, 2010, 7(3): 172-174.
|